{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:11Z","timestamp":1792790411200,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,24]]},"DOI":"10.1097\/qad.0b013e32833c93ce","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T05:44:10Z","timestamp":1279777450000},"page":"1991-2000","source":"Crossref","is-referenced-by-count":124,"title":["Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy"],"prefix":"10.1097","volume":"24","author":[{"given":"Stefania","family":"Piconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Trabattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Parisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Meraviglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Capetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Rizzardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/00002030-200009080-00011","article-title":"Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy","volume":"14","author":"Wood","year":"2000","journal-title":"AIDS"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/00002030-200109280-00002","article-title":"Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function","volume":"15","author":"Teixeira","year":"2001","journal-title":"AIDS"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/319678","article-title":"Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study","volume":"183","author":"Viard","year":"2001","journal-title":"J Infect Dis"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"183","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/500843","article-title":"Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV\/HIV-coinfected women: role of HCV on expression of primed\/memory T cells","volume":"193","author":"Al-Harthi","year":"2006","journal-title":"J Infect Dis"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00002030-199904160-00007","article-title":"Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen","volume":"13","author":"Renaud","year":"1999","journal-title":"AIDS"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/315171","article-title":"Immunrecostitution in the first year of potent antiretroviral therapy and its relationship with virologic response","volume":"181","author":"Connick","year":"2000","journal-title":"J Infect Dis"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00002030-200012010-00002","article-title":"Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase","volume":"14","author":"Lederman","year":"2000","journal-title":"AIDS"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1086\/375372","article-title":"Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes","volume":"187","author":"Kalayjian","year":"2003","journal-title":"J Infect Dis"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000226789.51992.3f","article-title":"Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1 positive subjects: results from ACTG 384","volume":"42","author":"Gandhi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","article-title":"HIV-infected adults with a CD4 cell count greater than 500 cells\/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population","volume":"46","author":"Lewden","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QAI.0b013e31804d685b","article-title":"CD4 cell counts of 800 cells\/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells\/mm3 or greater","volume":"45","author":"Gras","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/597093","article-title":"Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment","volume":"48","author":"Kelley","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations","volume":"20","author":"Kim","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells","volume":"200","author":"French","year":"2009","journal-title":"J Infect Dis"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial traslocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/mi.2009.129","article-title":"Cycling of gut mucosal CD4 T cells decreases after prolonged antiretroviral therapy and is associated with plasma LPS levels.","volume":"3","author":"Ciccone","year":"2010","journal-title":"Mucosal Immunol"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00281-009-0158-3","article-title":"Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection","volume":"31","author":"Hofer","year":"2009","journal-title":"Semin Immunopathol"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/135965350901400310","article-title":"Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection","volume":"14","author":"Tincati","year":"2009","journal-title":"Antivir Ther"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/COH.0b013e3282f9ae9c","article-title":"The mucosal barrier and immune activation in HIV pathogenesis","volume":"3","author":"Brenchley","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/339383a0","article-title":"Interleukin-2 production used to detect antigenic peptide recognition of HIV synthetic peptides recognition by T helper lymphocytes from asymptomatic HIV-seropositive individuals","volume":"339","author":"Clerici","year":"1989","journal-title":"Nature"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"AIDS"},{"key":"R26-3-20210130","first-page":"11","article-title":"The DAD study: a large European database looks at heart attacks.","volume":"21","year":"2009","journal-title":"TreatmentUpdate"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/QAD.0b013e32832e9b78","article-title":"Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy","volume":"23","author":"Marin","year":"2009","journal-title":"AIDS"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/135965350901400207","article-title":"The pathogenesis of liver disease in the setting of HIV-hepatitis virus B coinfection","volume":"14","author":"Iser","year":"2009","journal-title":"Antivir Ther"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/j.1532-5415.2009.02494.x","article-title":"Human immunodeficiency virus in an aging population, a complication of success","volume":"57","author":"Kirk","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/978-0-387-71767-8_24","article-title":"Pathogen-specific innate immune response","volume":"598","author":"Cary","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bcp.2006.07.010","article-title":"Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity","volume":"72","author":"Doyle","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R35-3-20210130","first-page":"114","article-title":"HIV disease progression: immune activation, microbes, and a leaky gut","volume":"15","author":"Douek","year":"2007","journal-title":"Top HIV Med"},{"key":"R36-3-20210130","first-page":"126","article-title":"Toll-like receptor and chemokine receptor expression in HIV-infected T lymphocyte subsets","volume":"75","author":"Miller Sanders","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ni1511","article-title":"Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses","volume":"8","author":"Denning","year":"2007","journal-title":"Nat Immunol"},{"key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"11","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/aid.2008.0140","article-title":"Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression","volume":"25","author":"Cao","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.200838667","article-title":"High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts","volume":"39","author":"Bi","year":"2009","journal-title":"Eur J Immunol"},{"key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.intimp.2009.03.009","article-title":"Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART","volume":"9","author":"Terzieva","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/597801","article-title":"Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells","volume":"199","author":"Card","year":"2009","journal-title":"J Infect Dis"},{"issue":"1 Suppl","key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1111\/j.1365-2567.2008.02978.x","article-title":"The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term nonprogressors","volume":"128","author":"Jiao","year":"2009","journal-title":"Immunology"},{"key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e328319edc0","article-title":"HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection","volume":"22","author":"Kared","year":"2008","journal-title":"AIDS"},{"key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R47-3-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.20021633","article-title":"Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharied","volume":"197","author":"Caramalho","year":"2003","journal-title":"J Exp Med"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.intimp.2009.01.027","article-title":"Regulatory T cells and toll-like receptors: what is the missing link?","volume":"9","author":"Dai","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.4049\/jimmunol.176.5.2808","article-title":"Regulated compartimentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells","volume":"176","author":"Raimondi","year":"2006","journal-title":"J Immunol"},{"key":"R50-3-20210130","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood-2002-10-3065","article-title":"B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression","volume":"101","author":"Trabattoni","year":"2003","journal-title":"Blood"},{"key":"R51-3-20210130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2008.03.001","article-title":"Mechanism of T regulatory cell function","volume":"7","author":"Askenasy","year":"2008","journal-title":"Autoimmun Rev"},{"key":"R52-3-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2008.03.015","article-title":"Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo","volume":"376","author":"Venkatachari","year":"2008","journal-title":"Virology"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","article-title":"Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction","volume":"179","author":"D'Souza","year":"2007","journal-title":"J Immunol"},{"key":"R54-3-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201008240-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:27:12Z","timestamp":1786040832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201008240-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":52,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833c93ce","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}